Valuation FDC Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:08 2026-07-13 EDT			5-day change	1st Jan Change
428.00 ^INR	-0.99%		-0.57%	+1.16%

05-27	FDC Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-27	F D C March-quarter consol profit 1.03 billion rupees	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	33,502	48,229	43,367	42,564	69,121	64,196
Change	-	43.96%	-10.08%	-1.85%	62.39%	-7.13%
Enterprise Value (EV) ¹	28,332	42,822	38,304	38,036	64,572	59,046
Change	-	51.14%	-10.55%	-0.7%	69.77%	-8.56%
P/E	14.1x	16.1x	20x	22x	22.8x	24.1x
PBR	2.17x	2.78x	2.22x	2.15x	3.3x	2.81x
PEG	-	0.6x	-0.7x	-2.46x	0.4x	-2x
Capitalization / Revenue	2.49x	3.62x	2.84x	2.39x	3.56x	3.05x
EV / Revenue	2.11x	3.21x	2.51x	2.13x	3.32x	2.8x
EV / EBITDA	9.5x	13.1x	15.6x	15.7x	19.6x	18.7x
EV / EBIT	10.6x	14.5x	17.7x	17.9x	21.6x	21.8x
EV / FCF	18.6x	32.7x	159x	349x	76.6x	27.8x
FCF Yield	5.39%	3.05%	0.63%	0.29%	1.31%	3.6%
Dividend per Share ²	0.8	-	-	-	-	5
Rate of return	0.41%	-	-	-	-	1.27%
EPS ²	13.94	17.73	12.82	11.67	18.59	16.39
Distribution rate	5.74%	-	-	-	-	30.5%
Net sales ¹	13,442	13,332	15,279	17,838	19,429	21,081
EBITDA ¹	2,981	3,267	2,461	2,424	3,297	3,152
EBIT ¹	2,673	2,962	2,164	2,120	2,986	2,711
Net income ¹	2,399	3,013	2,164	1,940	3,052	2,668
Net Debt ¹	-5,170	-5,407	-5,063	-4,529	-4,549	-5,150
Reference price ²	195.95	285.70	256.90	256.55	424.55	394.30
Nbr of stocks (in thousands)	170,973	168,810	168,810	165,910	162,810	162,810
Announcement Date	9/8/20	9/6/21	8/29/22	9/4/23	9/3/24	8/29/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30.1x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.78x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.81x	5.6x	30.89x	2.5%	161B
Average	16.07x	6.44x	16.43x	2.44%	397.1B
Weighted average by Cap.	23.83x	7.85x	18.15x	2%